Click a link below to view the mailing archive as if it had been sent to you.
2010-08-31 12:00 | | Pfizer Clot Drug Beats Aspirin in Research, May Enter $10 Billion Market and more... |
2010-08-31 00:00 | | Stem Cell Ruling Ripples Through U.S. Life Science Industry and more... |
2010-08-30 12:00 | | Eisai's Anti-Clotting Drug May Cut Heart Risks Without Increased Bleeding and more... |
2010-08-30 00:00 | | Sanofi Goes Public With Genzyme Offer for First Time . and more... |
2010-08-28 12:00 | | Genzyme shortages ease and more... |
2010-08-27 12:00 | | Lilly wins longer halt of generic Strattera sales and more... |
2010-08-27 00:00 | | These Are the Top 10 Pharma Underperform Calls and more... |
2010-08-26 12:00 | | Novartis Completes Purchase of Alcon Majority Stake from Nestle and more... |
2010-08-26 00:00 | | P&G to Help Somaxon Promote Insomnia Drug and more... |
2010-08-25 12:00 | | Takeda's Actos Has Same Heart Risks as Glaxo's Avandia, Researchers Find and more... |
2010-08-25 00:00 | | Pro Picks In Big Pharma Paying Big Dividends and more... |
2010-08-24 12:00 | | HPV Vaccine Rate Rises Among Teenage Girls and more... |
2010-08-24 00:00 | | Johnson & Johnson recalls contact lenses overseas and more... |
2010-08-23 12:00 | | Renegade Researcher Says AlzheimerâÔö£é?öé??Ôö£é?ö?ñós Drugs From Bristol-Myers, Pfizer May Be Unsafe Or Ineffective and more... |
2010-08-23 00:00 | | The Economics of Drug Discovery: 'First in Class' vs. 'Best in Class' and more... |
2010-08-22 00:00 | | TIME: Glaxo Knew of Avandia Heart Attack Risk and more... |
2010-08-21 12:00 | | Dividends Aren't Enough: Biotech |
2010-08-21 00:00 | | Drugmaker Elan Tempts the SEC to Investigate Its Tangled, Undisclosed Deals and more... |
2010-08-20 12:00 | | Impax Labs challenges Vytorin patents and more... |
2010-08-20 00:00 | | Cephalon sues Apotex in Nuvigil patent dispute and more... |
2010-08-19 12:00 | | [video]They Just Don't Get Lilly! and more... |
2010-08-19 00:00 | | Any Sanofi Deal For Genzyme May Take Time, At Limited Price and more... |
2010-08-18 12:00 | | Biogen Idec licenses Lou Gehrig's disease drug and more... |
2010-08-18 00:00 | | Novartis Well-Positioned to Buy AlconâÔö£é?öé??Ôö£é?ö?ñós Minority Shares and more... |
2010-08-17 12:00 | | Buffett Restores J&J Holdings as Berkshire's Cash Hoard Climbs and more... |
2010-08-17 00:00 | | Big Pharma's Big Problem and more... |
2010-08-16 12:00 | | Good News for Cell Therapeutics and more... |
2010-08-16 00:00 | | Empty Tables: One year in, restaurants feel sting of medical gift ban and more... |
2010-08-15 00:00 | | Another Twist in the Chronicles of Avandia! . and more... |
2010-08-14 00:00 | | PDL tumbles on Roche patent dispute and more... |
2010-08-13 12:00 | | Is Gilead Sciences Growing Foolishly? and more... |
2010-08-13 00:00 | | Pfizer: Strengths, Weaknesses, Opportunities, Threats and more... |
2010-08-12 12:00 | | MannKind / Seaside 88: Not Good News for Investors and more... |
2010-08-12 00:00 | | Goodbye to the ADHD Patch: After 9 Recalls and a Federal Probe, Shire Gives Up and more... |
2010-08-11 12:00 | | Did the Market Overreact to Curis's Latest Setback? and more... |
2010-08-11 00:00 | | Popular Bone Drugs Don't Raise Esophageal, Stomach Tumor Risk, Study Finds and more... |
2010-08-10 12:00 | | PDL BioPharma's Magic Formula and more... |
2010-08-10 00:00 | | Dendreon's in Trouble and more... |
2010-08-09 12:00 | | GTx loss widens in second quarter and more... |
2010-08-09 00:00 | | Bill pushes for new drugs for rare pediatric illnesses and more... |
2010-08-08 00:00 | | Response Genetics total revenue for second-quarter 2010 increases 197% to $5.6 million and more... |
2010-08-07 00:00 | | GenVec says new Novartis deal could yield $13M and more... |
2010-08-06 12:00 | | Ardea takes larger 2Q loss on development costs and more... |
2010-08-06 00:00 | | Watson Pharma Beats; Adjusts View and more... |
2010-08-05 12:00 | | Alexza Pharmaceuticals to raise $18M in stock sale and more... |
2010-08-05 00:00 | | Santarus Beats on Higher Revs and more... |
2010-08-04 12:00 | | ZymoGenetics 2Q loss narrows on sales, revenue and more... |
2010-08-04 00:00 | | Vivus slides after analyst downgrades to 'Sell' and more... |
2010-08-03 12:00 | | Cypress Biosciences up 22% in pre-market trading and more... |
2010-08-03 00:00 | | Allergan's Botox Migraine Review Extended Three Months by U.S. Regulators and more... |
2010-08-02 12:00 | | AstraZeneca Settlement Terms in Almost 4,000 Seroquel Cases to Stay Secret and more... |
2010-08-02 00:00 | | Teva Looks to Latin America for Growth and more... |